Trial record 4 of 5 for:    craniosacral

Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Zia, Al Raza
Sponsor:
Information provided by (Responsible Party):
Zia, Al Raza
ClinicalTrials.gov Identifier:
NCT01989013
First received: November 14, 2013
Last updated: May 4, 2014
Last verified: May 2014
  Purpose

We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.


Condition Intervention
Parkinson's Disease
Other: biweekly treatment intervention

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Resource links provided by NLM:


Further study details as provided by Zia, Al Raza:

Primary Outcome Measures:
  • reduction in tremors due to Parkinson's disease in the patient [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction


Secondary Outcome Measures:
  • Quality of Proprioception [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.


Other Outcome Measures:
  • Overall emotional State and sleep quality [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    will evaluate the overall emotional and sleeping habits on the measurement scale of 1-10 where 1 being emotionally stable and positive with 8 hours of quality sleep and 10 being emotionally unstable and have less than 4 hours of sleep at night and at the end of research will graphically and statistically provide the outcome of the above mentioned measure.


Estimated Enrollment: 9
Study Start Date: February 2014
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
CranioSacral manual therapy for parkinson's Other: biweekly treatment intervention

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • must be Diagnosed with Parkinson's Disease

Exclusion Criteria:

  • Anyone without Parkinson's Disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01989013

Contacts
Contact: Al Raza, MsT, CST, CRM 2486885920 alrazazia@gmail.com

Locations
United States, Michigan
IBR, Inc. Recruiting
Ann Arbor, Michigan, United States, 48104
Contact: Al Raza, MsT, CST    248-688-5920    alrazazia@gmail.com   
Principal Investigator: Al Raza, MsT, CST         
Sponsors and Collaborators
Zia, Al Raza
Investigators
Study Chair: Al Raza, MsT, CST, CRM IBR, Inc.
  More Information

Additional Information:
No publications provided

Responsible Party: Zia, Al Raza
ClinicalTrials.gov Identifier: NCT01989013     History of Changes
Other Study ID Numbers: CST001
Study First Received: November 14, 2013
Last Updated: May 4, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Zia, Al Raza:
Parkinson's disease
Craniosacral therapy
cranial osteopathy

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on October 19, 2014